Beneficial Treatment Management with Trifluridine/Tipiracil in a Patient with Metastatic Colorectal Cancer and Pronounced Hematological Event History during Previous Treatments

Trifluridine/tipiracil (FTD/TPI) significantly improves overall survival in patients with metastatic colorectal cancer (mCRC). The most common treatment-related event (grade ≥3) was hematological toxicity. We here report long-term disease-stabilizing FTD/TPI treatment of an mCRC patient (KRAS wild-t...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaechele, Volker, Hess, Jürgen, Schneider-Kappus, Wolfgang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5836196/
https://www.ncbi.nlm.nih.gov/pubmed/29515409
http://dx.doi.org/10.1159/000486195

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5836196/
https://www.ncbi.nlm.nih.gov/pubmed/29515409
http://dx.doi.org/10.1159/000486195

Ejemplares similares